{"status": "Ok", "redirect_url": "https://bristolmyers2016ir.q4web.com/iframes/press-releases/press-release-details/2026/Bristol-Myers-Squibb-Announces-Opdivo-nivolumab-in-Combination-with-AVD-Receives-Expanded-EU-Label-with-Approval-in-Frontline-Advanced-Classical-Hodgkin-Lymphoma/default.aspx", "message": "News view counter 769537 successfully enlarged"}